BioFIT Event

🌟[#MainSupporter2025 BioFIT] At BioFIT, we are thrilled to collaborate with partners who share our vision of innovation in Life Sciences. Today, we’re putting the spotlight on TEMIS Technopole, one of our Main Supporters, as they share their insights and expertise in an exclusive interview. 🎤 Curious about their role at #BioFIT2025 and what they hope to achieve? Check out our interview with Bruno Favier, director of TEMIS, to learn more! #lifesciences #innovation #temis #healthtech Marine Pentier - Vincent Tavernier - Yingjie WENG

🐾 From human health innovation to Animal Health impact How can a technology originally developed for human drug discovery create significant value in animal health? At #BioFIT2025, Dr. Kathrin Ladetzki-Baehs, co-founder of the MorphoSys spinout adivo GmbH - now part of Zoetis, will share the fascinating journey of how a human phage-display platform was adapted to develop antibodies for dogs and cats, ultimately leading to adivo’s successful acquisition by Zoetis, the world’s largest animal health company. Learn how strategic thinking, early-stage innovation, and cross-sector vision can turn cutting-edge science into tangible value, and how partnerships and spinouts can accelerate impact in both human and veterinary medicine. 📅 Tuesday, December 2nd | 3.00 - 3.30 pm 👉 Check the full programme and register today: https://lnkd.in/eQkCKJP4 #animalhealth #drugdiscovery #healthtech #veterinarymedicine Eline Delcroix - Marine Pentier - Vincent Tavernier

🌍 From innovation to impact: Preparing healthtech for global success in 2026 2026 will bring new risks, new regulations and fierce global competition. How can European medtech, biotech, and digital health innovators stay ahead and grow internationally while retaining R&D and talent at home? At #BioFIT2025, join the session “From innovation to impact: Growing globally competitive innovation ecosystems in the new realities of 2026” to explore: • Real-world case studies across Europe that inform strategies for international expansion • Emerging opportunities for collaboration with US industry, investors, and researchers • Insights on navigating regulatory shifts, economic pressures, and changing healthcare landscapes Participants will also receive complimentary access to the 2026 Internationalisation Readiness Roadmap workshop, providing actionable frameworks and tools to de-risk plans and seize global opportunities. 📅 Tuesday, December 2nd | 2.00 - 3.00 pm 🎤 Hosted by Venture Atlas Labs, experts in helping life science and healthtech innovators scale globally with precision and purpose. More information & registration: https://lnkd.in/ehuE6Ew8 #globalexpansion #internationalisation #venturecapital Marine Pentier - Vincent Tavernier

🚀 How do investors spot the next breakthrough in academia? Early-stage science is where the future of life sciences is being shaped, but not every project gets noticed. How do investors evaluate academic opportunities? What makes a project attractive, and what raises red flags? How can academics build relationships that lead to funding and impact? At #BioFIT2025, our panel “Early-Stage Sourcing: How Are Investors Approaching Academia Partnerships?” will uncover how investors and venture builders identify, assess, and support promising academic innovations. Speakers: • Kevin Dolowy Dalgaard, Lundbeckfonden / Lundbeck Foundation BioCapital • Damien BERTRAND, Sopartec sa • Nadia Benallal, Servier • Leigh Brody, AlbionVC Moderator: Dr. Markus A. Lang, Dr Lang Consulting 📅 Wednesday, December 3 | 11.30 am - 12.30 pm 👉 Discover the full programme and register today: https://lnkd.in/eQkCKJP4 #earlystageinvestment #academiaindustry #venturecapital #healthtech Eline Delcroix - Louise Olivier - Marine Pentier - Vincent Tavernier

We are delighted to welcome Maÿlis Deschamps, Associate at Kurma Partners, to the BioFIT Steering Committee! 🎉 Maylis joined Kurma Partners in 2022 and is part of the Kurma Growth Opportunities Fund, which invests in maturing European companies across the Biotech and HealthTech sectors. A scientist by training, Maylis holds a degree in Biomedical Science from King’s College London, with a focus on immuno-oncology, as well as a Strategy and Finance degree from ESSEC Business School. We are excited to have her expertise on board and sincerely thank her for joining our Steering Committee. Please join us in giving Maylis a warm welcome! 👏 #steeringcommittee #lifesciences #investor

💰 𝐍𝐚𝐯𝐢𝐠𝐚𝐭𝐢𝐧𝐠 𝐞𝐚𝐫𝐥𝐲-𝐬𝐭𝐚𝐠𝐞 𝐢𝐧𝐯𝐞𝐬𝐭𝐦𝐞𝐧𝐭𝐬 𝐢𝐧 𝐋𝐢𝐟𝐞 𝐒𝐜𝐢𝐞𝐧𝐜𝐞𝐬 The European life sciences investment landscape is evolving rapidly. In 2025, investors have become more selective, yet innovation continues to attract attention. How did early-stage financing perform this year? What lessons can be applied for 2026? At #BioFIT2025, our session “Assessing 2025 early-stage investments and expectations for 2026” will explore where capital is flowing, which ventures are catching investors’ eyes, and the trends shaping the year ahead. You’ll hear from Juliette Lee (EQT Life Sciences), Emeric Nouailhac (Wellington Partners), and Sofia Arnal (AdBio partners), under the moderation of Farzad Abdi-Dezfuli (Sarsia), all bringing hands-on experience in early-stage investment across Europe. 📅 Wednesday, December 3rd | 3.30 - 4.15 pm 👉 Check out the full programme and register: https://lnkd.in/eQkCKJP4 #earlystageinvestment #healthtech #innovationecosystem #venturecapital Eline Delcroix - Louise Olivier - Marine Pentier - Vincent Tavernier

🔬 Rethink health innovation - Shaping the future of testing in Europe #BioFIT2025 is proud to host the STEP4NAMs workshop, an exclusive session dedicated to the transformative shift brought by New Approach Methodologies (NAMs), from organoids and 3D-printed models to organ-on-chip systems and digital twins. 📍 Tuesday, December 2nd, 2025 As Europe accelerates toward more ethical, efficient, and sustainable testing solutions, this workshop will dive into the real barriers and opportunities driving NAM adoption across North-West Europe. Join us to: ✔️ Hear insights from experts across policy, industry, and academia ✔️ Explore the latest STEP4NAMs research findings ✔️ Discuss concrete challenges such as fragmented infrastructure and limited funding ✔️ Connect with a cross-border network shaping the future of BioPharma & MedTech innovation Join the conversation and help accelerate the adoption of next-generation testing methods that advance healthcare while reducing reliance on animal testing. #healthinnovation #NAMs #CrossBorderCollaboration Fanny Boyaval - Margot Jehle - Lotte Konings - Yaella Essed - Ralf Kemkemer - Joaquín Penide Durán, PhD - Kévin PLOUCHART

🔧 Turning academic innovation into industry-ready opportunities Academic research is bursting with high-value innovations, but making them visible, understandable, and attractive to industry partners is the real challenge. How do you make sure your asset gets noticed? How do you connect with the right stakeholders instead of relying on chance? At #BioFIT2025, our session “Best practices to proactively connect academic assets to potential partners” will dive into concrete, field-tested strategies to strengthen visibility, sharpen value propositions, and build meaningful bridges between academia and industry. You’ll hear from Lídia Fonseca (Universidade do Porto), Prabhu Velusami, MD (Johnson & Johnson) and Giulia Vestri, Ph.D., MBA (Claris Ventures), under the moderation of Dr. Markus A. Lang; all bringing hands-on experience from tech transfer, scouting, and early-stage investment. 📅 Tuesday, December 2nd | 4.15 - 5.00 pm 👉 Check out the full programme and register: https://lnkd.in/eQkCKJP4 #techtransfer #innovationecosystem #academiaindustry #TTO #collaboration Eline Delcroix - Louise Olivier - Marine Pentier - Vincent Tavernier

We are delighted to welcome Captech Santé as a Contributing Sponsor of #BioFIT2025! 💡 Launched in 2021, CAPTECH Santé is an early-stage investment fund supporting innovative projects in Biotech, Medtech, Digital Health and Nutrition. With a capital of €35-40 million, the fund invests in Seed and Series A rounds. Thanks to its strong expertise and deep integration within the healthcare ecosystem, Captech Santé provides long-term support to its portfolio companies and actively co-invests with international funds. We are proud to count Captech Santé among the partners contributing to innovation and growth in the life sciences ecosystem. 🤝 #LifeSciences #biotech #medtech #healthinnovation Vincent Tavernier - Marine Pentier

🎗️ Fostering innovation in oncology with Cancéropôle Est We are proud to host Cancéropôle Est at #BioFIT2025 for a dedicated session spotlighting the latest breakthroughs and emerging players shaping the future of oncology. Bringing together more than 1,000 scientists and clinicians, Cancéropôle Est drives progress across prevention, diagnosis and treatment for over 8.4 million inhabitants across the Grand Est and Burgundy–Franche-Comté regions. Their mission: strengthen cancer research by uniting academia, clinical institutions, industry partners and patients. During this special 2-hour programme, key leaders, innovators and CEOs will share insights on: 🔬 Major advances in oncology over the past decade 🧬 First-in-class therapies and precision medicine 🤖 AI-powered drug discovery 🎯 New-generation ADCs and microenvironment-targeted approaches 💉 Breakthroughs in cell therapy and immunotherapy An exceptional deep dive into the next wave of oncology innovation, from early science to clinical translation. Discover the full programme and secure your access: https://lnkd.in/eDMiEkTD #oncology #cancerresearch #innovation #healthtech Alicia Rosati - Marine Pentier - Vincent Tavernier - Guillaume Vetter-Genoud, PhD, MBA - Marie-Julie Tilly, PhD, MBA - Mehdi Chelbi - Sébastien Vachenc - Meddy El Alaoui - Albin JEANNE - Jean-Marc LIMACHER - Florent Gros